Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults
- 1 September 2014
- Vol. 32 (43) , 5657-5661
- https://doi.org/10.1016/j.vaccine.2014.08.011
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Human papillomavirus detection in women with and without human immunodeficiency virus infection in ColombiaBMC Cancer, 2014
- Incidence of and risk factors for type-specific anal human papillomavirus infection among HIV-positive MSMAIDS, 2014
- Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected WomenClinical Infectious Diseases, 2014
- Anal, Penile, and Oral High-Risk HPV Infections and HPV Seropositivity in HIV-Positive and HIV-Negative Men Who Have Sex with MenPLOS ONE, 2014
- Global Burden of Human Papillomavirus and Related DiseasesPublished by Elsevier ,2012
- Characteristics of HPV infection over time in European women who are HIV‐1 positiveBJOG: An International Journal of Obstetrics and Gynaecology, 2012
- The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, RwandaBMC Infectious Diseases, 2011
- HPV infection and cervical disease: A reviewAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2011
- Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected MenThe Journal of Infectious Diseases, 2010
- Human papillomavirus-associated diseases in HIV-infected men who have sex with menCurrent Opinion in Infectious Diseases, 2009